Form 4: Bausch Health Director Receives RSUs

Sarah B. Kavanagh, a Director at Bausch Health Companies Inc., was granted restricted share units valued at $250,000.

Summary

• Sarah B. Kavanagh, a Director of Bausch Health Companies Inc. (BHC), received an award of restricted share units (RSUs) on May 22, 2026.
• The RSUs have a grant date value of $250,000.
• These RSUs will vest on the day before the Issuer's next Annual Meeting of Shareholders.
• The RSUs will be settled in common shares of Bausch Health Companies Inc.
• Following this transaction, Ms. Kavanagh beneficially owns 282,230 common shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation award to a director rather than a significant financial event or strategic shift.

Positives

• Director Sarah B. Kavanagh received a significant award of restricted share units valued at $250,000, indicating continued investment in and alignment with the company's performance by its board.
• The RSUs are structured to vest prior to the next annual meeting, suggesting a focus on near-to-medium term performance and retention.

Future Outlook

The RSUs are set to vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, with settlement in common shares.

Industry Context

StockSavvy.ai notes that the granting of restricted share units to non-employee directors is a common practice in the pharmaceutical and healthcare industry to align executive and director interests with shareholder value and to aid in talent retention.

Stakeholder Impact

• Shareholders: The award of RSUs aligns director interests with shareholder value, potentially leading to decisions that benefit common stock performance. The settlement in common shares could slightly increase the number of outstanding shares.
• Employees: While not directly impacting employees, such compensation practices can be indicative of the company's overall compensation philosophy.
• Management: The award reinforces the alignment between the board and executive leadership.

Next Steps

• Vesting of RSUs on the date immediately preceding the Issuer's next Annual Meeting of Shareholders.
• Settlement of RSUs in common shares of Bausch Health Companies Inc.

Key Dates

Keywords

Bausch Health Companies Inc., BHC, Form 4, SEC Filing, Director Compensation, Restricted Share Units, RSUs, Beneficial Ownership, Insider Trading